Faced with the explosion in demand, the antidiabetic Ozempic will be reserved for patients already treated
2023-12-06 17:47:38 The drug met with global success on social networks thanks to “its weight-loss properties”, leading to stock shortages in certain countries. The Danish laboratory Novo Nordisk recommended on Wednesday December 6 that health professionals in France only prescribe its antidiabetic Ozempic to patients already treated, in order to ensure continuity of care, in … Read more